Natures NATR Crushes Q1 2026 Estimates EPS 030 Tops Views Pelthos Therapeutics PTHS Drifts Near 2711 as Market Awaits Catalyst 20260521 Liberty LILA Q1 2026 Underperforms Key Challenges Ahead TrumpXi Summit in Beijing Concludes Key Takeaways for USChina Relations